Healthcare -
Biotechnology - NASDAQ - US
$ 344.74
1.91 %
$ 7.52 B
Market Cap
-13.77
P/E
MDGL - COST OF REVENUE
Cost of Revenue MDGL - Madrigal Pharmaceuticals, Inc.
527 K
LAST VALUE
14.07%
2 YEAR CAGR
40.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR